BeStock  

Ironwood Pharmaceuticals IRWD

US equityMarket cap rank #3604Drug Manufacturers - Specialty & Generic
$3.75 +$0.12 (+3.31%)
Pre-market · Oct 8, 9:00 am ET · After hours $3.54 -5.59%
Open$3.58
Prev close$3.63
Day range$3.54 – $3.87
Volume2.05M
Market cap$619.65M
P/E (TTM)4.7
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$113.04M+32.6% YoY
Operating profit$79.31M+76.0% YoY
Net profit$51.29M+117.3% YoY
Diluted EPS$0.31+121.4% YoY
Free cash flow$58.28M+486.7% YoY
Operating cash flow$58.28M

Revenue, last 8 quarters

$91.6MSep '24$90.5MDec '24$41.1MMar '25$85.2MJun '25$122.1MSep '25$47.7MDec '25$106.5MMar '26$113.0MJun '26

Net profit, last 8 quarters

$3.6MSep '24$2.3MDec '24$-37.4MMar '25$23.6MJun '25$40.1MSep '25$-2.3MDec '25$40.8MMar '26$51.3MJun '26

Diluted EPS by quarter

0.02Sep '240.02Dec '24-0.23Mar '250.14Jun '250.23Sep '25-0.01Dec '250.24Mar '260.31Jun '26

Free cash flow by quarter

$9.9MSep '24$15.2MDec '24$19.9MMar '25$-15.1MJun '25$47.6MSep '25$74.6MDec '25$5.1MMar '26$58.3MJun '26

Annual revenue

$389.5MFY20$413.8MFY21$410.6MFY22$442.7MFY23$351.4MFY24$296.2MFY25

Profitability & balance sheet

Operating margin60.6%
Net margin33.4%
Return on assets41.4%
Current ratio6.06
Liabilities / assets156.8%
Cash & investments$79.13M
Total debt$393.58M
Net cash (debt)-$314.45M
Free cash flow / sales47.7%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $113.04M $106.51M $296.15M $47.71M $122.06M
Total Operating Revenue $113.04M $106.51M $296.15M $47.71M $122.06M
Operating Expense $33.73M $33.97M $177.39M $41.16M $44.38M
Selling and Admin Expenses $11.31M $12.03M $82.26M $19.29M $21.91M
Research & Development $22.42M $21.94M $95.14M $21.86M $22.47M
Operating Profit $79.31M $72.53M $118.76M $6.55M $77.68M
Net Non-Operating Interest Income (Expense) -$5.62M -$7.44M -$28.67M -$6.43M -$7.50M
Non-Operating Interest Income $1.59M $1.70M $4.08M $1.46M $930,000.00
Non-Operating Interest Expense $7.20M $8.97M $32.75M $7.89M $8.43M
Other Income (Expense) $42,000.00 $82,000.00 -$20.06M $329,000.00 -$2.16M
Special Income (Charges) $0.00 $40,000.00 -$20.26M $252,000.00 -$2.20M
-Less:Restructuring and Mergern & Acquisition $0.00 -$40,000.00 $20.26M -$252,000.00 $2.20M
Other Non-Operating Income (Expenses) $42,000.00 $42,000.00 $193,000.00 $77,000.00 $40,000.00
Pretax Profit $73.73M $65.17M $70.03M $455,000.00 $68.02M
Tax $22.44M $24.40M $46.01M $2.73M $27.94M
Net Profit $51.29M $40.77M $24.02M -$2.28M $40.08M
Profit from Continuing Operations $51.29M $40.77M $24.02M -$2.28M $40.08M
Net Income to Parent Company $51.29M $40.77M $24.02M -$2.28M $40.08M
Net Income to Common Stockholders $51.29M $40.77M $24.02M -$2.28M $40.08M
Basic EPS $0.31 $0.25 $0.15 -$0.01 $0.25
Diluted EPS $0.31 $0.24 $0.15 -$0.01 $0.23
Total Other Finance Costs – $175,000.00 – – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $285.13M $434.57M $396.90M $396.90M $396.06M
Total Current Assets $199.20M $332.29M $274.18M $274.18M $273.84M
Cash and Cash Equivalents & Short-Term Investments $79.13M $220.47M $215.46M $215.46M $140.41M
-Cash and Cash Equivalents $79.13M $220.47M $215.46M $215.46M $140.41M
Receivables $112.73M $105.84M $46.75M $46.75M $120.37M
-Accounts Receivable $112.73M $105.84M $46.75M $46.75M $120.37M
Other Current Assets $7.34M $5.98M $11.98M $11.98M $13.07M
Total Non-Current Assets $85.93M $102.27M $122.72M $122.72M $122.22M
Net PPE $11.36M $12.06M $12.75M $12.75M $13.44M
-Gross PPE $11.36M $12.06M $20.75M $20.75M $13.44M
Goodwill and Other Intangible Assets $1.63M $1.84M $2.04M $2.04M $2.25M
-Other Intangible Assets $1.63M $1.84M $2.04M $2.04M $2.25M
Non-Current Deferred Assets $69.06M $84.24M $103.43M $103.43M $101.69M
Other Non-Current Assets $3.87M $4.14M $4.50M $4.50M $4.84M
Total Liabilities $446.97M $651.71M $658.74M $658.74M $660.22M
Total Current Liabilities $32.85M $236.31M $242.22M $242.22M $242.50M
Payables $5.19M $7.13M $3.83M $3.83M $2.27M
-Accounts Payable $911,000.00 $3.24M $2.90M $2.90M $1.61M
-Total Tax Payable $4.28M $3.89M $927,000.00 $927,000.00 $656,000.00
Current Accrued Expenses $12.12M $12.07M $13.36M $13.36M $18.99M
Short-Term Debt and Capital Lease Obligation $3.29M $203.12M $202.93M $202.93M $202.74M
-Current Capital Lease Obligation $3.29M $3.27M $3.25M $3.25M $3.24M
Current Deferred Liabilities $1.25M $1.47M $1.11M $1.11M $1.05M
Other Current Liabilities $3.52M $5.98M $9.41M $9.41M $6.83M
Total Non-Current Liabilities $414.12M $415.40M $416.52M $416.52M $417.72M
Long Term Debt and Capital Lease Obligation $393.58M $394.23M $394.87M $394.87M $395.50M
-Long Term Debt $385.00M $385.00M $385.00M $385.00M $385.00M
-Long Term Capital Lease Obligation $8.58M $9.23M $9.87M $9.87M $10.50M
Other Non-Current Liabilities $20.54M $21.17M $21.65M $21.65M $22.22M
Total Equity -$161.84M -$217.14M -$261.84M -$261.84M -$264.16M
Stockholders' Equity -$161.84M -$217.14M -$261.84M -$261.84M -$264.16M
Capital Stock $165,000.00 $165,000.00 $163,000.00 $163,000.00 $163,000.00
-Common Stock $165,000.00 $165,000.00 $163,000.00 $163,000.00 $163,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.42B $1.42B $1.41B $1.41B $1.41B
Retained Earnings -$1.58B -$1.63B -$1.67B -$1.67B -$1.67B
Gains/Losses Not Affecting Retained Earnings -$324,000.00 -$795,000.00 -$1.06M -$1.06M -$1.71M
-Current Debt – $199.86M $199.68M $199.68M $199.51M
-Accumulated Depreciation – – -$8.01M -$8.01M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $58.28M $5.12M $127.04M $74.58M $47.58M
Net cash flow from continuing operations $58.28M $5.12M $127.04M $74.58M $47.58M
Net Income from Continuing Operations $51.29M $40.77M $24.02M -$2.28M $40.08M
Depreciation & Depletion & Amortization $457,000.00 $443,000.00 $1.88M $460,000.00 $475,000.00
Deferred Tax $15.17M $19.20M $40.80M -$1.75M $27.77M
Other Non-Cash Items $842,000.00 $863,000.00 $1.67M -$835,000.00 $844,000.00
Change in Working Capital -$12.72M -$59.81M $41.34M $75.15M -$25.21M
-Change in Receivables -$6.89M -$59.10M $35.15M $73.62M -$34.19M
-Change in Prepaid Assets -$1.42M $6.00M $367,000.00 $1.09M -$248,000.00
-Change in Payables and Accrued Expense -$3.49M -$5.99M $2.10M -$592,000.00 $9.53M
-Change in Other Current Assets $17,000.00 $121,000.00 $2.14M $1.79M $63,000.00
-Change in Other Current Liabilities -$944,000.00 -$840,000.00 $1.59M -$753,000.00 -$354,000.00
Net cash flow from investing $0.00 $0.00 -$34,000.00 $1,000.00 -$2,000.00
Net Cash Flow from Continuing Investing Activities $0.00 $0.00 -$34,000.00 $1,000.00 -$2,000.00
Net PPE Purchase and Sale $0.00 $0.00 -$34,000.00 $1,000.00 -$2,000.00
Financing Cash Flow -$199.70M $0.00 $216,000.00 $122,000.00 $0.00
Net Cash Flow from Continuing Financing Activities -$199.70M $0.00 $216,000.00 $122,000.00 $0.00
Proceeds from Stock Option Exercised $303,000.00 $0.00 $216,000.00 $122,000.00 $0.00
Ending Cash Balance $79.13M $220.47M $215.46M $215.46M $140.41M
Net Change in Cash -$141.42M $5.12M $127.23M $74.70M $47.58M
Beginning Cash Balance $220.47M $215.46M $88.56M $140.41M $92.85M
Effect of Exchange Rate Changes $77,000.00 -$106,000.00 -$329,000.00 $351,000.00 -$26,000.00
Free Cash Flow $58.28M $5.12M $127.01M $74.58M $47.58M
Gain/Loss from Continuing Operations – – $89,000.00 -$3,000.00 $7,000.00
Net Issuance Payments Of Debt – – $0.00 $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on IRWD.

Leave a comment

Scroll to Top